[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601115":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":28,"responsibleParty":48,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":10,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":70,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Heidelberg University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"First trimester",null,"patients scheduled for routine first trimester ultrasound assessment",{"label":13,"type":10,"description":14,"interventionNames":10},"Second trimester","patients scheduled for routine anomaly scan in second trimester",[16],{"name":17,"affiliation":18,"role":19},"Dr. med. Alexandra von Au","University Heidelberg","PRINCIPAL_INVESTIGATOR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Anna S Dr. med. Anna Scholz, MD","CONTACT","+49 6221 56 32080","anna.scholz@med.uni-heidelberg.de",{"name":27,"role":23,"phone":10,"phoneExt":10,"email":10},"Alexandra von Au, MD",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Heidelberg University Hospital, Department of Gynecology and Obstetrics","RECRUITING","Heidelberg","69120","Germany","DE",{"type":37,"coordinates":38},"Point",[39,40],8.69079,49.40768,{"lat":40,"lon":39},[43,45,47],{"name":44,"role":23,"phone":24,"phoneExt":10,"email":25},"Dr. med. Anna Scholz",{"name":17,"role":23,"phone":10,"phoneExt":10,"email":46},"alexandra.vonau@med.uni-heidelberg.de",{"name":17,"role":19,"phone":10,"phoneExt":10,"email":10},{"type":19,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Anna Scholz","Principal Investigator","100601115","hyperspectral-imaging-for-prediction-of-preeclampsia-100601115",false,"NCT07106294","Hyperspectral Imaging for Prediction of Preeclampsia","Systematic Evaluation of Hyperspectral Analysis as a Predictive Marker of Preeclampsia","HIPPA","Inclusion Criteria:\n\n* singleton pregnancies\n* age ≥ 18 years\n* patient's ability to provide consent\n* written informed consent\n* women scheduled for a routine ultrasound scan in first or second trimester\n\nExclusion Criteria:\n\n* lack of consent\n* language barrier\n* severe fetal chromosomal\u002Fgenetic\u002Fstructural anomalies known at study enrollment\n* smoking in the last two hours before measurement\n* diagnosis of preeclampsia at study enrollment",true,"FEMALE","18 Years",{"count":63,"type":64},1430,"ESTIMATED","OBSERVATIONAL","Preeclampsia is a hypertensive pregnancy disorder that can quickly lead to serious, potentially life-threatening outcomes for both the mother and the fetus. Typical features of preeclampsia are by endothelial and microvascular dysfunctionsNotably, such impairments in endothelial function may precede preeclampsia diagnosis and canpersist for years postpartum. In clinical practice, however, no predictive methods have yet been established that specifically reflect endothelial dysfunction in the context of preeclampsia.\n\nHyperspectral imaging represents a new and non-invasive imaging modality that allows contact-free visualization of peripheral microcirculatory dynamics and tissue perfusion. Despite its growing use in other medical fields, this technology has not yet been systematically studied to determine its predictive potential in preeclampsia.\n\nThe HIPPA project (Systematic Evaluation of Hyperspectral Analysis for Prediction of Preeclampsia) is a prospective observational study to evaluate the applicability of hyperspectral imaging as a new tool for prediction of preeclampsia.",[68,69],"Preeclampsia (PE) Risk","Preeclampsia",[71,72,73,74],"preeclampsia","hyperspectral imaging","EASIX","endothelial dysfunction","2025-08-24",{"date":77,"type":78},"2025-08-29","ACTUAL",{"date":80,"type":78},"2025-08-21",{"date":82,"type":64},"2027-07-01",{"name":5,"class":6},1]